Investing

Cargo Therapeutics : CRGX

CRGX

Stock Data

$4.47

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

CARGO Therapeutics Inc is a trailblazer in the biotechnology sector, focusing on developing advanced treatments for cancer through chimeric antigen receptor (CAR) T-cell therapies. Its flagship project, CRG-022, aims to combat B-cell malignancies by targeting CD22, a crucial tumor antigen. Additionally, the company is working on CRG-023, a pioneering tri-specific CAR T therapy that targets three B-cell antigens simultaneously. Founded in 2019 and based in San Mateo, California, CARGO Therapeutics is dedicated to revolutionizing cancer treatment.

All Cargo Therapeutics Articles

2 Articles

Trey Thoelcke | Jun 9, 2024 at 9:15 AM EDT

Huge Insider Buying at a Software Giant, Railroad Operator, and More

In the past week, insiders returned to scoop up more shares of a fracking services company and a recreational boat…

Trey Thoelcke | Dec 1, 2023 at 10:50 AM EST

Insiders Are Loading Up on These Biotech and Energy Stocks

Notable insider buying in the past week included biotech and energy companies, including some that have just gone public. Also,…